Skip to main content

Ovarian Cancer Lawsuit Against J&J's Talcum Powder

Ovarian Cancer Lawsuit Against J&J's Talcum Powder

Ovarian Cancer Lawsuit Against J&J's Talcum Powder

Introduction

A New Jersey woman filed a product liability lawsuit against Johnson & Johnson (J&J) in the U.S. District Court for the District of Columbia on June 10, alleging that the talcum powder caused her ovarian cancer, after years of applying the product for feminine hygiene.

According to the court documents, the plaintiff used J&J’s Baby Powder and Shower-to-Shower powder products from July 1965 until June 2016, following which she developed ovarian cancer. The case joins other J&J’s Baby Powder lawsuits and Shower-to-Shower lawsuits pending in courts nationwide, which make similar allegations that the defendants have known for decades about the potential link between talcum powder and ovarian cancer, yet failed to warn consumers. In a similar trial held earlier this month, a jury awarded $325 million to a plaintiff diagnosed with mesothelioma caused by talcum powder. Also, last year a Missouri jury returned a landmark $4.7 billion verdict for 22 women diagnosed with ovarian cancer.

Nearly 12,000 J&J Baby Powder lawsuits and Shower-to-Shower lawsuits are pending in courts nationwide, claiming that asbestos exposure from the company’s talc-based products causes ovarian cancer or mesothelioma. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J., overlook J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.